Physician profile
Harrison Goodno
NPI 1942512959
$1,443.30
in general payments reported to CMS, 2019-2025
10 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2022: $51.46 · 2023: $989 · 2024: $25.78 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $749 · Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $748.57 |
| Food and Beverage | $374.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $933.25 | 2023-2025 | Iovera, Zilretta |
| Trice Medical, INC. | $218.72 | 2019 | |
| Bioventus LLC | $82.25 | 2019-2025 | Xcell |
| Abbvie INC. | $58.14 | 2023-2024 | |
| Djo, LLC | $38.89 | 2023 | Aircast, Donjoy |
| Depuy Synthes Sales INC. | $36.05 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $27.92 | 2025 | |
| Horizon Therapeutics Plc | $17.31 | 2019 | |
| Vericel Corporation | $15.41 | 2022 | |
| Exact Sciences Corporation | $15.36 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harrison Goodno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.